Ruinian Zheng

474 total citations
20 papers, 365 citations indexed

About

Ruinian Zheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruinian Zheng has authored 20 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruinian Zheng's work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Ruinian Zheng is often cited by papers focused on MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Ruinian Zheng collaborates with scholars based in China. Ruinian Zheng's co-authors include Jun Jia, Wei‐Biao Ye, Huiling Yuan, Chun Liu, Kejun Liu, Ruopeng Zhang, Wen‐Zhao Zhong, Juanjuan Zhang, Aixue Liu and Senming Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Ruinian Zheng

19 papers receiving 362 citations

Peers

Ruinian Zheng
Zijie Mei China
Adam Rzechonek Poland
Yejing Zhu China
Christiane Matuszcak Germany
Chunyang Zhang China
Sandra Lettlová Czechia
Jinduan Lin China
Heng‐Ying Pu China
Yongmei Yang China
Zijie Mei China
Ruinian Zheng
Citations per year, relative to Ruinian Zheng Ruinian Zheng (= 1×) peers Zijie Mei

Countries citing papers authored by Ruinian Zheng

Since Specialization
Citations

This map shows the geographic impact of Ruinian Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruinian Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruinian Zheng more than expected).

Fields of papers citing papers by Ruinian Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruinian Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruinian Zheng. The network helps show where Ruinian Zheng may publish in the future.

Co-authorship network of co-authors of Ruinian Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ruinian Zheng. A scholar is included among the top collaborators of Ruinian Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruinian Zheng. Ruinian Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Guanglong, et al.. (2025). IKZF1 promotes pyroptosis and prevents M2 macrophage polarization by inhibiting JAK2/STAT5 pathway in colon cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167690–167690. 1 indexed citations
2.
3.
Li, Wenxuan, et al.. (2024). Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer. Journal of Translational Medicine. 22(1). 474–474. 5 indexed citations
4.
5.
Guo, Dongbo, et al.. (2023). Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma. Heliyon. 9(7). e18065–e18065. 5 indexed citations
6.
Mo, Rujun, et al.. (2023). Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. Disease Markers. 2023. 1–15. 2 indexed citations
7.
Zheng, Ruinian, et al.. (2021). Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(1). 153–173. 10 indexed citations
8.
Zheng, Ruinian, Hongping Li, Yongkang Ye, et al.. (2021). Clinicopathological features and prognostic analysis of 77 patients with multiple primary cancers.. PubMed. 25(4). 2110–2116. 6 indexed citations
9.
Tong, Gangling, Lin Lin, Li Wang, et al.. (2020). <p>Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study</p>. Cancer Management and Research. Volume 12. 2481–2489. 6 indexed citations
10.
Zheng, Ruinian, Jun Jia, Huiling Yuan, et al.. (2020). Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer. Aging. 12(10). 8893–8912. 23 indexed citations
11.
Xu, Shun, Weijia Wu, Ailing Su, et al.. (2019). The p53/miRNAs/Ccna2 pathway serves as a novel regulator of cellular senescence: Complement of the canonical p53/p21 pathway. Aging Cell. 18(3). e12918–e12918. 59 indexed citations
12.
Zheng, Ruinian, Huiling Yuan, Kejun Liu, et al.. (2018). Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155/CDX1 axis. Biochemical and Biophysical Research Communications. 498(4). 1002–1008. 99 indexed citations
13.
Zheng, Ruinian, et al.. (2017). Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an in vitro and in vivo study. Oncology Letters. 14(1). 751–757. 3 indexed citations
14.
Liu, Aixue, Ruinian Zheng, Fan Yang, et al.. (2017). Effects of curcumin on growth of human cervical cancer xenograft in nude mice and underlying mechanism. Food Science and Technology. 38(1). 106–111. 10 indexed citations
15.
Zhang, Juanjuan, et al.. (2016). Risk of Congestive Heart Failure in Early Breast Cancer Patients Undergoing Adjuvant Treatment With Trastuzumab: A Meta-Analysis. The Oncologist. 21(5). 547–554. 38 indexed citations
16.
Zheng, Ruinian, Shuai Han, Chongyang Duan, et al.. (2015). Role of Taxane and Anthracycline Combination Regimens in the Management of Advanced Breast Cancer. Medicine. 94(17). e803–e803. 20 indexed citations
17.
Zheng, Ruinian, et al.. (2015). Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells. Molecular Medicine Reports. 13(2). 1570–1576. 29 indexed citations
18.
Chen, Bei, Ruinian Zheng, Duan Liu, et al.. (2012). The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer. Ultrasonics Sonochemistry. 20(2). 667–673. 35 indexed citations
19.
Zheng, Ruinian, et al.. (2010). [The sonodynamic effects of Chlorin e6 on the proliferation of human lung adenocarcinoma cell SPCA-1].. SHILAP Revista de lepidopterología. 13(3). 201–5. 4 indexed citations
20.
Gao, Huijie, et al.. (2010). [Adriamycin enhances the sonodynamic effect of chlorin e6 against the proliferation of human breast cancer MDA-MB-231 cells in vitro].. PubMed. 30(10). 2291–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zijie Mei Breakdown of academic impact, for papers by Adam Rzechonek Breakdown of academic impact, for papers by Yejing Zhu Breakdown of academic impact, for papers by Christiane Matuszcak Breakdown of academic impact, for papers by Chunyang Zhang Breakdown of academic impact, for papers by Sandra Lettlová Breakdown of academic impact, for papers by Jinduan Lin Breakdown of academic impact, for papers by Heng‐Ying Pu Breakdown of academic impact, for papers by Yongmei Yang
Rankless by CCL
2026